Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
2018 1
2020 1
2021 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Cardiac automaticity: basic concepts and clinical observations.
Vetulli HM, Elizari MV, Naccarelli GV, Gonzalez MD. Vetulli HM, et al. J Interv Card Electrophysiol. 2018 Aug;52(3):263-270. doi: 10.1007/s10840-018-0423-2. Epub 2018 Aug 15. J Interv Card Electrophysiol. 2018. PMID: 30112616 Review.
Supernormal excitability and conduction.
Rosenbaum MB, Levi RJ, Elizari MV, Vetulli HM, Sánchez RA. Rosenbaum MB, et al. Among authors: vetulli hm. Cardiol Clin. 1983 Feb;1(1):75-92. Cardiol Clin. 1983. PMID: 6399994 Review.
RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one.
Rothlin RP, Pelorosso F, Duarte M, Nicolosi L, Fernandez Criado I, Salgado MV, Vetulli H. Rothlin RP, et al. Among authors: vetulli h. Rev Port Cardiol. 2024 Apr;43(4):219-220. doi: 10.1016/j.repc.2023.08.005. Epub 2023 Nov 6. Rev Port Cardiol. 2024. PMID: 37940073 Free article. English, Portuguese. No abstract available.
Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID-19.
Rothlin RP, Pelorosso FG, Duarte M, Nicolosi L, Ignacio FC, Salgado MV, Vetulli H. Rothlin RP, et al. Among authors: vetulli h. Pharmacol Res Perspect. 2023 Apr;11(2):e01083. doi: 10.1002/prp2.1083. Pharmacol Res Perspect. 2023. PMID: 37038324 Free PMC article. No abstract available.
Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial.
Duarte M, Pelorosso F, Nicolosi LN, Salgado MV, Vetulli H, Aquieri A, Azzato F, Castro M, Coyle J, Davolos I, Criado IF, Gregori R, Mastrodonato P, Rubio MC, Sarquis S, Wahlmann F, Rothlin RP. Duarte M, et al. Among authors: vetulli h. EClinicalMedicine. 2021 Jun 18;37:100962. doi: 10.1016/j.eclinm.2021.100962. eCollection 2021 Jul. EClinicalMedicine. 2021. PMID: 34189447 Free PMC article.